Results 341 to 350 of about 7,719,266 (361)

From Trials to Trials

2016
Scott H. Podolsky, David S. Jones, Ted J. Kaptchuk   +2 more
openaire   +1 more source

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Lancet, The, 2002
Stephen B Hanauer, Stefan Schreiber
exaly  

Clinical trials

Current Opinion in Lipidology, 2018
openaire   +2 more sources

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Ling-Long Tang, Wen-Fei Li, Xu Liu
exaly  

MAIA under the microscope — bringing trial design into focus

Nature Reviews Clinical Oncology, 2019
Prashant Kapoor, S Vincent Rajkumar
exaly  

Drug Trials

Journal of Parenteral and Enteral Nutrition, 2004
openaire   +2 more sources

Novel clinical trial designs emerging from the molecular reclassification of cancer

Ca-A Cancer Journal for Clinicians
Mina Nikanjam, Shumei Kato, Jason K Sicklick   +2 more
exaly  

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial

Lancet, The, 2002
Irene M Stratton, Peter Sandercock
exaly  

Cancer therapy and the randomized clinical trial: good medicine?

Ca-A Cancer Journal for Clinicians, 1994
exaly  

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
Jianqing Zhu, Mo Chen, Ning Li
exaly